Get started
Author

Shogo Matsuda

Observed names: MATSUDA, Shogo, Matsuda, Shogo, S Matsuda, S. Matsuda
ORCID: 0000-0003-0023-3616
Observed ORCID: 0000-0003-0023-3616
OpenAlex ID: A5037460997
Exploration of pathomechanism using comprehensive analysis of serum cytokines in polymyositis/dermatomyositis-interstitial lung disease
2019 · Shogo Matsuda, Takuya Kotani, et al. · Lara D. Veeken · 45
CCL2 produced by CD68+/CD163+ macrophages as a promising clinical biomarker of microscopic polyangiitis-interstitial lung disease
2021 · Shogo Matsuda, Takuya Kotani, et al. · Lara D. Veeken · 34
The comparison of nailfold videocapillaroscopy findings between anti-melanoma differentiation-associated gene 5 antibody and anti-aminoacyl tRNA synthetase antibody in patients with dermatomyositis complicated by interstitial lung disease
2020 · Reiko Wakura, Shogo Matsuda, et al. · Scientific Reports · 27
PDF
Evaluation of poor prognostic factors of respiratory related death in microscopic polyangiitis complicated by interstitial lung disease
2021 · Shogo Matsuda, Takuya Kotani, et al. · Scientific Reports · 26
PDF
Adipose-derived mesenchymal stem cell therapy for connective tissue diseases and complications
2024 · Takuya Kotani, Takashi Saito, et al. · Inflammation and Regeneration · 22
Examination of nailfold videocapillaroscopy findings in ANCA-associated vasculitis
2022 · Shogo Matsuda, Takuya Kotani, et al. · Lara D. Veeken · 18
PDF
Prediction model for respiratory-related mortality in microscopic polyangiitis with interstitial lung disease: multicentre REVEAL cohort study
2023 · Shogo Matsuda, Takuya Kotani, et al. · Lara D. Veeken · 17
Long-term efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: a propensity score matching analysis in the multicenter REVEAL cohort study
2024 · Mayu Shiomi, Ryu Watanabe, et al. · Frontiers in Immunology · 16
PDF
Eosinophilic granulomatosis with polyangiitis complicated by subarachnoid hemorrhage and coronary vasculitis: a case report and review of the literature
2017 · Shogo Matsuda, Shuzo Yoshida, et al. · Rheumatology International · 16
Therapeutic effects of adipose-derived mesenchymal stem/stromal cells with enhanced migration ability and hepatocyte growth factor secretion by low-molecular-weight heparin treatment in bleomycin-induced mouse models of systemic sclerosis
2022 · Takayasu Suzuka, Takuya Kotani, et al. · Arthritis Research & Therapy · 15
PDF
Asymptomatic rheumatoid meningitis revealed by magnetic resonance imaging, followed by systemic rheumatic vasculitis: A case report and a review of the literature
2016 · Shogo Matsuda, Shuzo Yoshida, et al. · Modern Rheumatology · 15
Comparison of therapeutic effects of combination therapy with prednisolone and tacrolimus or azathioprine on progressive interstitial pneumonia with systemic sclerosis
2021 · Takao Kiboshi, Takuya Kotani, et al. · Modern Rheumatology · 14
Aggressive multi‐combination therapy for anti‐MDA5 antibody‐positive dermatomyositis‐rapidly progressive interstitial lung disease
2023 · Kenichiro Hata, Takuya Kotani, et al. · International Journal of Rheumatic Diseases · 13
Serum Complement C4 Levels Are a Useful Biomarker for Predicting End-Stage Renal Disease in Microscopic Polyangiitis
2023 · Shogo Matsuda, Katsumasa Oe, et al. · International Journal of Molecular Sciences · 12
PDF
Association of M2 Macrophages, Th2, and B Cells With Pathomechanism in Microscopic Polyangiitis Complicated by Interstitial Lung Disease
2022 · Shogo Matsuda, Takuya Kotani, et al. · The Journal of Rheumatology · 11
Adipose-derived stem/stromal cells with heparin-enhanced anti-inflammatory and antifibrotic effects mitigate induced pulmonary fibrosis in mice
2022 · Takashi Saito, Takuya Kotani, et al. · Biochemical and Biophysical Research Communications · 10
Risk prediction model for mortality in microscopic polyangiitis: multicentre REVEAL cohort study
2023 · Takuya Kotani, Shogo Matsuda, et al. · Arthritis Research & Therapy · 9
PDF
Factors associated with drug retention of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis: A multicentre REVEAL cohort study
2024 · Mayu Shiomi, Ryu Watanabe, et al. · Modern Rheumatology · 8
Risk factors for serious infections and infection-related mortality in patients with microscopic polyangiitis: Multicentre REVEAL cohort study
2024 · Atsushi Manabe, Keiichiro Kadoba, et al. · Modern Rheumatology · 8
Human MIKO-1, a Hybrid Protein That Regulates Macrophage Function, Suppresses Lung Fibrosis in a Mouse Model of Bleomycin-Induced Interstitial Lung Disease
2022 · Takuya Kotani, Masaki Ikemoto, et al. · International Journal of Molecular Sciences · 6
PDF
Long‐term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA‐associated vasculitis in multicenter REVEAL cohort study
2025 · Shogo Matsuda, Takuya Kotani, et al. · Journal of Internal Medicine · 5
PDF
Risk prediction model for relapse of anti-synthetase syndrome-associated interstitial lung disease in Japanese multicentre MYKO cohort study
2025 · Shogo Matsuda, Takuya Kotani, et al. · Lara D. Veeken · 5
Differences in Organ Damage Based on Age at Onset in Idiopathic Inflammatory Myopathies: A Retrospective Multicenter MYKO Study
2025 · Hideaki Tsuji, Yuki Aitani, et al. · Internal Medicine · 5
PDF
Identification of novel clinical subtypes in patients with microscopic polyangiitis using cluster analysis: multicenter REVEAL cohort study
2025 · Ayana Okazaki, Shogo Matsuda, et al. · Frontiers in Immunology · 5
PDF
Poor prognostic factors for relapse of interstitial lung disease in microscopic polyangiitis: the Japanese multicentre REVEAL cohort study
2024 · Shogo Matsuda, Takuya Kotani, et al. · Arthritis Research & Therapy · 5
PDF
Works count: 66
Citation count: 402
H-index: 13
I10-index: 16
Year
Topic
Type